Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adhesion G protein-coupled receptor G1 (ADGRG1), commonly known as GPR56, is a member of the adhesion GPCR subfamily, distinguished by a large and modular extracellular domain mediating cell–cell and cell–matrix interactions[1][3]. The receptor undergoes autoproteolysis at a GPCR autoproteolysis-inducing (GAIN) domain, generating an N-terminal fragment (NTF) and a C-terminal fragment (CTF) that remain non-covalently associated until dissociation triggers signaling via a tethered agonist (the “Stachel” sequence)[1][2][4]. ADGRG1/GPR56 plays essential roles in neuronal migration, cortical and oligodendrocyte development, and is a critical modulator of platelet activation through G13 signaling in response to collagen and shear stress[1][2][4][5]. Mutations cause developmental brain malformations, and altered expression/function is implicated in tumor progression (notably melanoma) and hemostatic disorders[5]. The receptor interacts with several ligands (e.g., collagen III in the brain, collagen I in platelets), with therapeutic targeting subject to risks due to its diverse roles in the nervous system and the vasculature[1][2][4].
Activation through N-terminal fragment dissociation, exposing a tethered peptide agonist (“Stachel” sequence) that activates intracellular G protein (mainly Gα13) signaling[2][4]. Ligand-induced (e.g., collagen III, collagen I) activation and downstream RhoA pathway stimulation[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adhesion G protein-coupled receptor G1 (ADGRG1).